Etiome

Biotechnology Research • 140 1st St, Cambridge, United States • 21-50 Employees

Company overview

Headquarters	140 1st St, Cambridge, Massachusetts 02141, US
Website	etiome.bio
NAICS	541714
Keywords	Biotechnology, Drug Discovery, Artificial Intelligence
Founded	2021
Employees	21-50

Key Contacts at Etiome

Caleb Kennedy

Senior Director, Health Data Science

Joseph Zullo

Associate Director

Artem Sokolov

Senior Director, Head Of Computational Biology

Jonathan Fillatre

Director

Etiome Email Formats

Etiome uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@etiome.bio), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@etiome.bio	100%

About Etiome

At Etiome, we envision a world where people can live healthier and longer. By building and applying detailed models of how biology shifts over the course of disease, we aim to develop Biostaged Medicines –therapies specific to disease stage, delivered to the right patient population at the right time. Our Temporal Biodynamics™ platform applies expansive population data, single cell omics, and machine learning to accurately characterize the stages of disease progression and create targeted medicines designed to alter the course of disease. Founded by Flagship Pioneering with this vision of enabling a healthier future, Etiome is at the forefront of preemptive medicine by delivering Biostaged Medicines that halt or reverse the progression of disease across its continuum.

Etiome revenue & valuation

Annual revenue	$2,053,320
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$6,600,000
Total funding	$100,000,000